SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-13-000584
Filing Date
2013-01-31
Accepted
2013-01-31 16:55:40
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2212557z10-q.htm 10-Q 298411
2 EX-31.1 a2212557zex-31_1.htm EX-31.1 14646
3 EX-32.1 a2212557zex-32_1.htm EX-32.1 6938
10 G604248.JPG g604248.jpg GRAPHIC 16072
  Complete submission text file 0001047469-13-000584.txt   3345072

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20121231.xml EX-101.INS 244982
5 EX-101.SCH nutr-20121231.xsd EX-101.SCH 44221
6 EX-101.CAL nutr-20121231_cal.xml EX-101.CAL 58889
7 EX-101.DEF nutr-20121231_def.xml EX-101.DEF 149997
8 EX-101.LAB nutr-20121231_lab.xml EX-101.LAB 824536
9 EX-101.PRE nutr-20121231_pre.xml EX-101.PRE 386935
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 13563298
SIC: 2833 Medicinal Chemicals & Botanical Products